AbbVie (ABBV) Free Cash Flow (2012 - 2026)
AbbVie (ABBV) reported Free Cash Flow of $3.11 billion for Q2 2026, down 36.2% from $4.88 billion a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Free Cash Flow (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbbVie's Free Cash Flow came in at $18.21 billion, down 0.2% year-over-year; for FY2025, it came in at $17.82 billion, down 0.1% from FY2024.
- Free Cash Flow has declined for three consecutive years, though with a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- By year, Free Cash Flow came in at $17.83 billion in FY2024 (-19.2%), $22.06 billion in FY2023 (-9.0%), $24.25 billion in FY2022 (+10.3%) and $21.99 billion in FY2021 (+31.0%).
- The Q2 2026 figure ranks as the lowest quarterly Free Cash Flow since Q1 2025.
- Year over year, Free Cash Flow gained in four of the last eight quarters, with growth averaging 26.8%.
- The high point for year-over-year Free Cash Flow in five years was Q1 2026 (growth of 154.6%); the low point was Q2 2024 (a decline of 66.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.56 billion (Q1 2026), $4.89 billion (Q4 2025) and $6.64 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 6.20 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 3.63 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 1.01 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Bn |
| Mar 31, 2026 | 3.56 Bn |
| Dec 31, 2025 | 4.89 Bn |
| Sep 30, 2025 | 6.64 Bn |
| Jun 30, 2025 | 4.88 Bn |
| Mar 31, 2025 | 1.40 Bn |
| Dec 31, 2024 | 6.76 Bn |
| Sep 30, 2024 | 5.20 Bn |
| Jun 30, 2024 | 2.03 Bn |
| Mar 31, 2024 | 3.85 Bn |
| Dec 31, 2023 | 4.55 Bn |
| Sep 30, 2023 | 7.36 Bn |
| Jun 30, 2023 | 6.14 Bn |
| Mar 31, 2023 | 4.02 Bn |
| Dec 31, 2022 | 7.22 Bn |
| Sep 30, 2022 | 7.43 Bn |
| Jun 30, 2022 | 4.86 Bn |
| Mar 31, 2022 | 4.75 Bn |
| Dec 31, 2021 | 4.89 Bn |
| Sep 30, 2021 | 7.72 Bn |
API Access
AbbVie Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();